Email:   |  Call: 6109452007

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Biosimilar Reference Antibody

Biosimilar Reference  antibodies are similar to FDA-approved therapeutic antibodies in structure, function, and efficacy. Our biosimilar antibodies are developed with recombinant antibody technology using the same sequence as the original therapeutic (reference) antibody. They are validated for a number of research applications such as flow cytometry, blocking/neutralizing, and immunocytochemistry.   Biosimilars are a cost-effective alternative for assay development, facilitating development and validation of novel therapeutics.